This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Dr. Stiann Foss, PhD
Researcher at Oslo University Hospital
Speaker

Profile

I am a researcher in the Laboratory of Adaptive Immunity and Homeostasis at the University of Oslo, led by Professor Jan Terje Andersen. My research focuses on the interplay between antibodies and their cellular receptors, such as the neonatal Fc receptor (FcRn) and the cytosolic Fc receptor tripartite motif-containing 21 (TRIM21). By combining structural and biophysical approaches with biochemical, cellular, and in vivo experiments, knowledge from this basic research is used to inform innovative design of antibody molecules with improved functions and tailored modes of action. I am currently funded by the Research Council of Norway through its Young Research Talents program.

Agenda Sessions

  • Distinct Effects of IgG1 Fc Engineering for FcRn Mediated Half-life Extension on TRIM21 Engagement and Activity

    17:25